Synthesis of 2′-C-methyl ribonucleoside analogues with modified heterocyclic base moieties

Synthetic Communications

Volumn 40, Issue 20, 2010, Pages 2988-2999

  Kim, Myong Jung ^a  

^a FOUNDATION FOR APPLIED MOLECULAR EVOLUTION   (United States)

Author keywords

2 C methyl nucleoside; Antiviral agent; HCV

Indexed keywords

ANTIVIRUS AGENT; HETEROCYCLIC COMPOUND; RIBONUCLEOSIDE DERIVATIVE; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HEPATITIS C VIRUS; NONHUMAN; REACTION ANALYSIS; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 77956939331     PISSN: 00397911     EISSN: 15322432     Source Type: Journal    
DOI: 10.1080/00397910903349984     Document Type: Article

References (14)

1. Manns, M. P.; McHutchison, J. G.; Gordon, S. C.; Rustgi, V. K.; Shiffman, M.; Reindollar, R.; Goodman, Z. D.; Koury, K.; Ling, M.; Albrecht, J. K. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001, 358, 958.
2. (a) Patterson, J.; Fernandez-Larsson, R. Molecular mechanisms of action of ribavirin. Rev. Infect. Dis. 1990, 12, 1139
3. (b) Maag, D.; Castro, C.; Hong, Z.; Cameron, C. E. Hepatitis C virus RNA-dependent RNA polymerase (NS5B) as a mediator of the antiviral activity of ribavirin. J. Biol. Chem. 2001, 49, 46094
4. (c) Crotty, S.; Cameron, C. E.; Andino, R. RNA virus error catastrophe: Direct molecular test by using ribavirin. Proc. Natl. Acad. Sci. USA 2001, 98, 6895.
5. Carroll, S. S.; Tomassini, J. E.; Bosserman, M.; Getty, K.; Stahlhut, M. W.; Eldrup, A. B.; Bhat, B.; Hall, D.; Simcoe, A. L.; Lafemina, R.; Rutkowski, C. A.; Wolanski, B.; Yang, Z.; Migliaccio, G.; De Francesco, R.; Kuo, L. C.; MacCoss, M.; Olsen, D. B. Inhibition of hepatitis C virus RNA replication by 20-modified nucleoside analogs. J. Biol. Chem. 2003, 278, 11979.
6. Eldrup, A. B.; Allerson, C. R.; Bennett, C. F.; Bera, S.; Bhat, B.; Bosserman, M. R.; Brooks, J.; Burlein, C.; Carroll, S. S.; Cook, P. D.; Getty, K. L.; MacCoss, M.; MacMasters, D. R.; Olsen, D. B.; Prakash, T.; Prhavc, M.; Song, Q.; Tomassini, J. E.; Xia, J. Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase. J. Med. Chem. 2004, 47, 2283.
7. De Francesco, R.; Tomei, L.; Altamura, S.; Summa, V.; Migliaccio, G. Approaching a new era for hepatitis C virus therapy: Inhibitors of the NS3-4A serine protease and the NS5B RNA-dependent RNA polymerase. Antivir. Res. 2003, 58, 1.
8. Migliaccio, G.; Tomassini, J. E.; Carroll, S. S.; Tomei, L.; Altamura, S.; Bhat, B.; Bartholomew, L.; Bosserman, M. R.; Ceccacci, A.; Colwell, L. F.; Cortese, R.; De Francesco, R.; Eldrup, A. B.; Getty, K. L.; Hou, X. S.; LaFemina, R. L.; Ludmerer, S. W.; MacCoss, M.; McMasters, D. R.; Stahlhut, M. W.; Olsen, D. B.; Hazuda, D. J.; Flores, O. A. Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro. J. Biol. Chem. 2003, 278, 49164.
9. Julander, J. G.; Furuta, Y.; Shafer, K.; Sidwell R. W. Activity of T-1106 in a hamster model of yellow fever virus Infection. Antimicrob. Agents Chemother. 2007, 51, 1962.
10. Jordan, I.; Briese, T.; Fischer, N.; Lau, J. Y.-N.; Lipkin, W. I. Ribavirin inhibits West Nile virus replication and cytopathic effect in neutral cells. J. Infect. Dis. 2000, 182, 1214.
11. Seley, K. L.; ODaniel, P. I.; Salim, S. Design and synthesis of a series of chlorinated 3-deazaadenine analogs. Nucleosides, Nucleotides Nucl. Acids 2003, 22, 2133.
12. Franchetti, P.; Cappellacci, L.; Marchetti, S.; Trincavelli, L.; Martini, C.; Mazzoni, M. R.; Lucacchini, A.; Grifantini, M. 20-C-Methyl analogs of selective adenosine receptor agonists: Synthesis and binding studies. J. Med. Chem. 1998, 41, 1708.
13. Zhang, N.; Chen, H.-M.; Koch, V.; Schmitz, H.; Liao, C.-L.; Bretner, M.; Bhadti, V. S.; Fattom, A. I.; Naso, R. B.; Hosmane, R. S.; Borowski, P. Ring-expanded (fat) nucleoside and nucleotide analogs exhibit potent in vitro activity against Flaviviridae NTPases=helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus. J. Med. Chem. 2003, 46, 4149.
14. Talekar, R. R.; Wightman, R. H. Synthesis of pyrrolo[2,3-d]pyrimidine and 1,2,3-triazole isonucleosides. Tetrahedron 1997, 53, 3831.